INCubator for Antibacterial
Therapies in Europe

Great news for the hemolysin inhibitor program!

DH2024-10-21T11:38:38+02:0021. October 2024|

“Surviving Superbugs – A Dance To Resist”

credits: Interfinity On April 9th, 2025, 20:30, at [...]

DH2024-12-10T14:31:39+01:0017. October 2024|

Puray, together with Munich University of Applied Sciences, has been [...]

DH2024-12-09T17:29:43+01:0023. September 2024|

Photo credits: Phiogen PHIOGEN, a Texas-based venture developing off-the-shelf [...]

DH2024-09-23T12:03:39+02:0023. September 2024|

Photo credits: INCATE Cavenagh Health exists to foster innovation and [...]

DH2024-09-23T18:24:08+02:0023. September 2024|

Antimicrobial resistance (AMR) is a global growing threat. Only [...]

DH2024-09-23T13:55:42+02:0023. September 2024|

September 19th, 2024 – INCATE, the INCubator for Antibacterial Therapies [...]

DH2024-09-19T07:41:12+02:0019. September 2024|

September 10th, 2024 – INCATE, the INCubator for Antibacterial [...]

DH2024-09-10T08:11:09+02:0010. September 2024|

September 2nd, 2024 - INCATE (the INCubator for Antibacterial Therapies [...]

DH2024-09-02T08:12:51+02:002. September 2024|

The INCATE Selection Committee selected the new 6 ventures [...]

DH2024-08-19T12:22:19+02:0015. August 2024|